VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
ASX Limited vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ASX Limited
ASX · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Merck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: ASX Limited leads (80 / 100 vs 71 / 100 for Merck & Co., Inc.).
- Segment focus: ASX Limited has 4 segments (31.5% in Markets); Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Primary market structure: Duopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: ASX Limited has 4 moat types across 3 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
ASX Limited
Markets
Trading venues for Australian cash equities and exchange-traded derivatives (futures, options)
Australia
Brokers/market participants, proprietary trading firms, institutional investors
Market operator / trading venue
31.5%
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
ASX Limited strengths
Merck & Co., Inc. strengths
Segment mix
ASX Limited segments
Full profile >Listings
Quasi-Monopoly
Markets
Duopoly
Technology & Data
Competitive
Securities & Payments
Monopoly
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.